The Relative Strength (RS) Rating for Surgery Partners stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 74.
When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
IBD's unique RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks compares to the rest of the market.
Decades of market research shows that the best-performing stocks tend to have an RS Rating north of 80 in the early stages of their moves. See if Surgery Partners stock can continue to rebound and hit that benchmark.
See How IBD Helps You Make More Money In Stocks
Is Surgery Partners Stock A Buy?
Surgery Partners stock has pulled back below its 50-day moving average and is not currently offering a proper buying opportunity. See if the hospital operator stock goes on to build a promising consolidation that could kick off a new price move.
The hospital operator showed 0% EPS growth last quarter, while sales growth came in at 8%. The next quarterly results are expected on or around Aug. 1.
Surgery Partners stock earns the No. 3 rank among its peers in the Medical-Hospitals industry group. Surgery Partners and Select Medical Holdings are also among the group's highest-rated stocks.
